When cancer cells are treated with AICAR, a widely used AMP-Kinase activator, it resulted in S-phase growth arrest in an LKB1-independent fashion by inducing p53 and inhibiting Akt phosphorylation [96]. The gene discussed is STK11; the disease is cancer.